Liver allograft fibrosis and minimization of immunosuppression

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|1397-3142|7|667-668

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.1397-3142, Iss.7, 2015-11, pp. : 667-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus‐related cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1178-1184

John Wiley & Sons Inc

Access to resources Recommend Favorite

The need for minimization strategies: current problems of immunosuppression

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 8, 2015-08 ,pp. : 891-900

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver fibrosis: The hepatocyte revisited

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1659-1661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Allograft Fibrosis: Biology and Therapeutic Targets

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 4, 2015-04 ,pp. : 863-886

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of fibrosis in acute liver failure

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 7, 2015-07 ,pp. : 1877-1885

John Wiley & Sons Inc

Access to resources Recommend Favorite